elonva
organon (new zealand) limited - corifollitropin alfa 0.2 mg/ml; - solution for injection - 100 mcg/0.5ml - active: corifollitropin alfa 0.2 mg/ml excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.
elonva
organon (new zealand) limited - corifollitropin alfa 0.3 mg/ml; - solution for injection - 150 mcg/0.5ml - active: corifollitropin alfa 0.3 mg/ml excipient: hydrochloric acid methionine polysorbate 20 sodium citrate sodium hydroxide sucrose water for injection - controlled ovarian stimulation (cos) for the development of multiple follicles and pregnancy in women undergoing in-vitro fertilisation techniques.
fosamax
organon (new zealand) limited - alendronate sodium trihydrate 91.37mg equivalent to 70 mg alendronic acid - tablet - 70 mg - active: alendronate sodium trihydrate 91.37mg equivalent to 70 mg alendronic acid excipient: croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - fosamax is indicated: · in postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). · in postmenopausal women who are at risk of developing osteoporosis fosamax is indicated for the prevention of osteoporosis to reduce the risk of future fracture. · for the treatment of osteoporosis in men to prevent fractures. · for the treatment and prevention of glucocorticoid-induced osteoporosis in men, premenopausal women and postmenopausal women receiving oestrogen. · for treatment of paget's disease of bone in men and women.
fosamax plus
organon (new zealand) limited - alendronate sodium trihydrate 91.37mg equivalent to 70 mg alendronate anhydrous free acid; colecalciferol 140ug equivalent to 5600 iu; - tablet - 70/140 - active: alendronate sodium trihydrate 91.37mg equivalent to 70 mg alendronate anhydrous free acid colecalciferol 140ug equivalent to 5600 iu excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - fosamax plus is indicated for the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.
fosamax plus
organon (new zealand) limited - alendronate sodium trihydrate 91.37mg equivalent to to 70 mg anhydrous free acid; colecalciferol 70ug equivalent to 2800 iu; - tablet - 70/70 - active: alendronate sodium trihydrate 91.37mg equivalent to to 70 mg anhydrous free acid colecalciferol 70ug equivalent to 2800 iu excipient: colloidal silicon dioxide croscarmellose sodium lactose magnesium stearate microcrystalline cellulose - fosamax plus is indicated for the treatment of osteoporosis in select patients where vitamin d supplementation is recommended.
puregon
organon (new zealand) limited - follitropin beta 833 iu/ml; - solution for injection - 833 iu/ml - active: follitropin beta 833 iu/ml excipient: benzyl alcohol hydrochloric acid as 0.1n solution to adjust to ph 7.0 methionine polysorbate 20 sodium citrate dihydrate sodium hydroxide as 0.1n solution to adjust to ph 7.0 sucrose water for injection - in the female: - anovulatory infertility - controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programmes [e.g. in vitro fertilisation and related procedures].
orgalutran solution for injection 0.25 mg0.5 ml
organon singapore pte. ltd. - ganirelix - injection - 0.25 mg/0.5 ml - ganirelix 0.25 mg/0.5 ml
vytorin 1010 tablet
organon singapore pte. ltd. - ezetimibe; simvastatin - tablet - 10 mg - ezetimibe 10 mg; simvastatin 10 mg
vytorin 1020 tablet
organon singapore pte. ltd. - ezetimibe; simvastatin - tablet - 10 mg - ezetimibe 10 mg; simvastatin 20 mg
asmanex twisthaler 200 mcginhalation
organon singapore pte. ltd. - mometasone furoate - powder, metered - 200 mcg/inhalation - mometasone furoate 200 mcg/inhalation